Some mild effects, such as reduced appetite or occasional nausea, may persist longer but are usually manageable
After stopping the GLP-1 based therapy, participants receive Revita treatment in an open-label setting and take part in a structured diet and lifestyle program
Retatrutide as a broader GLP-1/GIP/GCG comparison point
Based on the results shown in the present manuscript, we can suggest that the follow-up of a HAD with pertinent adaptations could be used as a therapeutic aid to improve the balance of antioxidants and oxygen/nitrogen reactive species to the antioxidant side, where oxidative stress conditions persist
Preclinical studies in rodents with long-acting GIP, GLP-1, and GLP-2 analogues, alongside related clinical trials, suggest these molecules are safe, and furthermore, may improve overall bone health
One nice thing about Semaglutide is that it comes in both injection and oral forms